TrialCancer gene therapy2003

Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients.

John Nemunaitis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.